Hyperlipidemia Dyslipidemia

Featured Products

Product Description
Chapter 1: An Introduction to Cholesterol
Introduction
Cholesterol is a major structural component of all animal cells and is essential to mammalian cell function. In humans, cholesterol is an important molecular building block for steroid hormones, bile salts, and vitamin D. It is produced by the human body or digested and absorbed through the small intestine when animal products such as eggs, meat, fish, and dairy products are ingested. Healthy individuals produce approximately 1000 mg of cholesterol daily, representing approximately 75 % of the cholesterol metabolized in the human body. Intestinal daily uptake is approximately 300-500 g, representing the remaining 25 %. Cholesterol and its roles in the body are intensely studied as abnormal cholesterol metabolism can cause disease.

Table of Contents
Abbreviations and Acronyms
Introduction
Chapter 1: An Introduction to Cholesterol
Introduction
Lipid overview
Cholesterol
Carotenoids
Phospholipids
Triglycerides
Cholesterol and lipoproteins
Chylomicrons
HDL
IDL
LDL
VLDL
Apolipoproteins and lipoproteins
Cholesterol and disease
Conclusion
Chapter 2: Cholesterol Physiology
Cholesterol functions
Cholesterol catabolism
Cholesterol and bile salt synthesis
Cholesterol and steroid hormones
Cholesterol and oxysterols
Cholesterol and vitamin D
Cholesterol and lipoproteins
Chylomicrons and cholesterol metabolism
LDL and cholesterol metabolism
VLDL and cholesterol metabolism
HDL and cholesterol metabolism
Cholesterol and the plasma membrane
Cholesterol and the brain
Conclusion
Chapter 3: Cholesterol Homeostasis and Phatophysiology
Cholesterol homeostasis
De novo cholesterol biosynthesis
De novo cholesterol biosynthesis regulation
Cholesterol absorption
Dyslipidemias
Hyperlipoproteinemias
Hypercholesterolemia, atherosclerosis, and CVD
Hypocholesterolemia
Hypertriglyceridemia
Hyperalphalipoproteinemia
Hypoalphalipoproteinemia
Hepatobiliary cholesterol homeostasis
Cholesterol cholelithiasis
Cholestasis
Familial cholestasis
ICP
Cholesterol transport diseases
TD
CESD
Brain cholesterol disorders
Cholesterol and AD
Cholesterol and HD
Cholesterol and NP disease
Cholesterol and PD
Cholesterol and SLOS
Conclusion
Chapter 4: Genetics and Epigenetics of Cholesterol Homeostasis
Cholesterol and genetic, epigenetic, and environmental factors
Genetics of lipid metabolism and cholesterol homeostasis
Genetics of familial hyperlipoproteinemia
Genetics of familial hypercholesterolemia
Genetics of familial hypertriglyceridemia
Genetics of familial hyperalphalipoproteinemia
Genetics of familial hypoalphalipoproteinemia
Genetics of familial hypocholesterolemia
Abetalipoproteinemia
Hypobetalipoproteinemia
Chylomicron retention disease
Genetics of reverse cholesterol transport
Genetics of Tangier Disease
Genetics of CESD
Genetics of hepatobiliary cholesterol homeostasis
Genetics of cholesterol cholelithiasis
Genetics of cholestasis
Genetics of cholesterol brain disorders
Epigenetics of lipid metabolism and cholesterol homeostasis
DNA methylation and cholesterol
Histone modifications and cholesterol
MiRs and cholesterol
Epigenetics and dyslipidemia
Epigenetics of familial hypercholesterolemia
Conclusion
Chapter 5: Diagnosis and Management of Dyslipidemias
Hyperlipidemias
Hypercholesterolemia
Epidemiology
Symptoms
Diagnosis
Management
Diet and lifestyle modifications
Pharmacotherapy
Statins
LDL apheresis
Prognosis
Special concerns
Hypocholesterolemia
Epidemiology
Symptoms
Diagnosis
Management
Prognosis
Special concerns
Hypertriglyceridemia
Epidemiology
Symptoms
Diagnosis
Management
Prognosis
Special concerns
Cholesterol transport disorders
Tangier disease
Epidemiology
Symptoms
Diagnosis
Management
Special concerns
Cholesteryl ester storage disease
Epidemiology
Symptoms
Diagnosis
Management
Prognosis
Special concerns
Hyperalphalipoproteinemia
Epidemiology
Symptoms
Diagnosis
Manageme
Lipid Management: From Basics  to Clinic
$55.38

$79.99

Free shipping

Lipid Management: From Basics to Clinic
Product Description
This timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.

Questions & answers

  1. montana montana says:
    What does a diagnosis of dyszididemia sordid?
    Sheri F says:
    that is, an lump of lipids in the blood,. Did you mean Dyslipidemia. In western societies, most dyslipidemias are hyperlipidemias.
  1. Melatonin a new heaviness loss medicine?
    Saturday Sept 28, 2013 (foodconsumer.org) -- Researchers at University of Granada published a lucubrate in Journal of Pineal Research saying melatonin helps frustrate obesity or promote weight loss ... by their employment, jet lags and night shift etc.) do not sleep ...
  2. Melatonin Helps Steer Weight Gain: Research
    Melatonin is a unpremeditated hormone segregated by the body and usually melatonin levels enlarge in the dark at night. It is also found in fruit and vegetables like mustard, Goji berries, almonds, sunflower seeds, cardamom, fennel, coriander and ...
  3. Spanish scientists design melatonin consumption helps control moment gain
    Sleeping in the inky and consuming these foodstuffs could help control load gain and prevent cardiovascular diseases associated with weight and dyslipidemia.

Differences Between Dyslipidemia And Hyperlipidemia | Disagreement ...

In this article, we will be. In keeping our main part healthy, there are some things that we need to be aware of, and not just the right-mindedness kinds of food and knowing what types of edibles we should avoid. Dyslipidemia vs Hyperlipidemia.
Source: http://www.differencebetween.net/science/health/disease-health/differences-between-dyslipidemia-and-hyperlipidemia/

Google news feed

  1. Melatonin a new impact loss medicine?
    Melatonin has been known to specify metabolic benefits in treating diabetes and hyperlipidemia. The reported study offers an explanation why melatonin helps these medical conditions. Earlier, the researchers tested melatonin for its in truth on obesity
  2. Bioscience Technology Melatonin Controls Arrange Gain by Stimulating 'Beige Fat'
    Spanish scientists are the first place to reveal the previously unknown enigma of the intention melatonin has to counter obesity in the organism and why it has metabolic benefits in treating diabetes and hyperlipidemia. Melatonin is a imbecile hormone and
  3. Melatonin helps put down weight gain as it stimulates the appearance of 'beige ...
    the Clinic Carlos III, Madrid, and the University of Texas Fettle Science Center in San Antonio (USA) have revealed, for the first things, the previously unknown enigma of why melatonin has metabolic benefits in treating diabetes and hyperlipidemia
  4. Teva to discharge new generic drug in US
    has announced the throw of the generic equivalent to Niaspan tablets in the Collective States. The tablets help reduce lifted up "bad" cholesterol (LDL) and increase "righteous" cholesterol (HDL) in patients with primary hyperlipidemia and interbred dyslipidemia.
  5. Drug Discovery & Development Teva Launches Generic Niaspan in U.S.
    Niaspan is marketed by AbbVie and familiar with diet to reduce elevated TC, LDL-C, Apo B and TG levels, and to strengthen HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia. Niaspan had annual sales of approximately $1.12 billion in the 
blood (left for 4h) from patient with
blood (left for 4h) from patient with
in the management of hyperlipidemia dyslipidemia hypercholesterolemia
in the management of hyperlipidemia dyslipidemia hypercholesterolemia
Hyperlipidemia, Dyslipidemia, Hypercholesterolemia
Hyperlipidemia, Dyslipidemia, Hypercholesterolemia